Drugs / EM-100
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03489941 | Apr 2018 | conjunctivitis | Bausch & Lomb Incorporated | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EM-100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03489941 ↗ |
| Route | Other | “One drop of EM-100 in either the right or left eye once on Day 1.” NCT03489941 ↗ |